T2 Biosystems has received FDA clearance to add the capability to detect another bacterial species, Acinetobacter baumannii, to its panel. T2 Biosystems is set to report its fourth-quarter financial ...
LEXINGTON, Mass., April 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the ...
LEXINGTON, Mass., Oct. 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the ...
T2 Biosystems ( (TTOO)) has provided an update. T2 Biosystems, Inc. held its annual meeting of stockholders, where key corporate governance matters were addressed, including the approval of an ...
LEXINGTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the ...
LEXINGTON, Mass. and SAN DIEGO, Sept. 06, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, ...
LEXINGTON, Mass., Dec. 18, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the ...
Shares of T2 Biosystems Inc. extended their losing streak to two days Wednesday despite the biotech clinching regulatory approval for a key diagnostic test. In a statement Tuesday, T2 Biosystems TTOO ...
A Billerica landlord is suing T2 Biosystems for damages resulting from the biotech company abandoning its lease. Farley White sent a notice Jan. 17 that it was terminating the tenant's 70K SF lease at ...
T2 Biosystems, Inc. (NASDAQ:TTOO) shares are trading higher Tuesday, though the stock remains down by more than 75% over the last month. On Monday, T2 Biosystems announced the successful amendment and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results